IBRX Stock Heads For Best Week In Over 2 Months After Chairman Soon Shiong’s Cancer Vaccine Trial Milestone Update
Patrick Soon-Shiong said the trial has been fully accrued and passed its one-year mark. The Phase 2b trial is testing Tri-Ad5 vaccine in combination with Anktiva in patients with Lynch syndrome. Tri-Ad5 targets three proteins found on precancerous and cancer cells. The primary assessment at week 104 is expected around this time in 2027. ImmunityBio … Read more